Surrozen submits IND application for SZN-8141 to treat diabetic macular edema
Surrozen says it has submitted an IND application for SZN-8141 for the treatment of diabetic macular edema.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Surrozen submits IND application for SZN-8141 in diabetic macular edema
Surrozen (SRZN) announced it submitted an IND application for SZN-8141 for the treatment of diabetic macular edema.